Table 2.
Dose/Concentration | Name of Animal Model/Cell Lines | Route of Exposure | Duration of Exposure/Treatment | Results | Source |
---|---|---|---|---|---|
100 mg/kg b.w. Al + 50 mg/kg b.w. CUR | Sprague–Dawley rats | Al-drinking water/CUR-IP | Al-8 weeks/CUR-2 months (co-administration) | ↓TNF-α, ↓NF-kB p65, ↓NO activity |
[100] |
50 mg/kg/day Al + 30 mg/mL/kg b.w. CUR | Male Wistar rats | Al-drinking water/CUR-orally | 6 months (co-administration) | ↓lipid peroxidation in the brain, ↓SOD, GPx, GST and Na+, K+, ATPase |
[107] |
100 mg/kg Al + 30 or 60 mg/kg CUR | Male Wistar rats | Al-drinking water/CUR-orally | 42 days(co-administration) | ↓IAL, first and second RL to reach the platform in the pre-trained rats, ↑retention performance of the spatial navigation task; ↓MDA, nitrite levels, ↑reduced GSH, ↓GST, SOD, and catalase activity, ↓AChE activity, ↓Al in hippocampus |
[104] |
Synthesized [Al(CUR) (EtOH)2](NO3)2) complex | Binding of CUR complex to calf thymus-DNA | ↓affinity of Al to interact with DNA | [103] | ||
Synthesized Al (III)–CUR complexes | NMR, mass spectroscopy, ultraviolet, the generalized 2D UV–UV correlation spectroscopy, the density functional theory | ↓affinity of Al to interact with amyloid beta (Aβ) peptide, ↓ toxicity effect of Al on peptides, ↓ oxidative stress |
[102] |
Abbreviations: ↑ = increase; ↓ = decrease; CUR: curcumin; Al = aluminum; IP = intraperitoneal injection; TNF-α = tumor necrosis factor alpha; NF-κB p65 = nuclear factor kappa B p65 subunit; NO = nitric oxide; SOD = superoxide dismutase; GPx = glutathione peroxidase; GST = glutathione S-transferase; ATPase = adenosine triphosphatase; IAL = initial acquisition latencies; first RL = first retention latency; second RL = second retention latency; AChE = acetylcholinesterase; NMR = Nuclear magnetic resonance.